Dermatitis clinical trials at UCLA

1 in progress, 0 open to eligible people

Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis
Sorry, not currently recruiting here
This is a Phase 2a, multicenter, randomized, double-blind, placebo-controlled study with an open-label extension to evaluate the efficacy and safety of camoteskimab in adults with moderate to severe AD.
Los Angeles, California and other locations

Last updated: October 2, 2024